ArticleFrontiers in oncology2026

The impact of HER2 discordance on patient prognosis following anti-HER2 neoadjuvant therapy for HER2-positive breast cancer.

Yining Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.